ActiveAtlas Opportunity Score 78/100
Massachusetts DPH — Breast and Cervical Cancer Screenings (RFR 260134)
Open Massachusetts DPH / MBCCP blanket procurement for qualified providers of breast and cervical cancer screening and follow-up clinical services. Bid opening: February 28, 2034 at 4:00 PM; N9+ Fit 12/100.
FundingNo current maximum or contract ceiling is stated in the public COMMBUYS bid header. Atlas does not infer one.
DeadlineFebruary 28, 2034 at 4:00 PM. COMMBUYS does not separately identify a time-zone abbreviation in the public header.
Last verifiedSeptember 10, 2026
Required next actionReview the controlling RFR for provider qualifications, required registrations, clinical-service standards, pricing/payment terms, references, and submission requirements. COMMBUYS currently indicates an unfinished quote exists in the authenticated session, so reconcile that existing draft before initiating any new response. Do not initiate external outreach without eligibility, Email Opt-Out, global deduplication, and authorized non-Gmail channel checks.
Broad Eligibility
DPH/MBCCP is seeking qualified applicants able to provide breast and cervical cancer screenings and timely follow-up clinical services to program-eligible Massachusetts clients. The public COMMBUYS header does not fully enumerate all bidder entity types or mandatory qualifications; the controlling RFR must be reviewed before certifying any applicant or direct vendor as eligible.
Atlas Analysis
Statewide clinical-screening procurement with a long open enrollment horizon. N9+ Fit is 12/100 because remote physical examination does not replace mammography, cervical screening, or required clinical follow-up. QC Healthcare/direct Dr. Miltie fit remains low and unverified pending full provider-qualification review.
The Massachusetts Department of Public Health (DPH), Bureau of Community Health and Prevention, is maintaining an open blanket procurement for qualified applicants to provide breast and cervical cancer screenings and timely follow-up clinical services to Massachusetts Breast and Cervical Cancer Program (MBCCP) eligible clients.
The official COMMBUYS record identifies solicitation BD-25-1031-BCHAP-BCH01-108335, alternate ID 260134, and a bid opening of February 28, 2034 at 4:00 PM. The public bid header does not separately state a time-zone abbreviation. Electronic quotes are allowed. The contract period shown is November 1, 2024 through June 30, 2034.
MBCCP eligible clients include low-income and uninsured or underinsured individuals, with a special focus on populations experiencing inequities in breast and cervical cancer outcomes and people residing in rural areas. Current controlling materials listed by COMMBUYS include the RFR, application form, covered-services/CPT-code attachment, patient navigation and case-management attachment, consent form, reporting-data-elements attachment, Q&A, and intent-to-award notices.
Atlas assessment
Atlas Opportunity Score: 78/100. N9+ Fit: 12/100. The opportunity is legitimate statewide clinical-screening procurement intelligence, but the N9+ remote physical-exam platform is not a substitute for mammography, cervical screening, or required clinical follow-up. QC Healthcare/direct Dr. Miltie fit remains low and unverified until the controlling RFR’s provider qualifications and service-delivery requirements are fully reviewed. Atlas will not force a technology fit.
The public COMMBUYS header does not state a current maximum contract value. The authenticated procurement session also indicates an unfinished quote exists for this bid; Atlas therefore should not initiate a new quote until that existing draft state is reconciled. No external outreach is authorized solely from this listing.
Source verificationReferenced source · www.commbuys.comAtlas last verified this record September 10, 2026. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗
